Life sciences · Journal article
Frontiers in Immunology · November 6, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
The immune microenvironment of colorectal cancer (CRC) is characterized by pronounced cellular-state and spatial heterogeneity. B cells and macrophages bridge adaptive and innate immunity, respectively, and engage in bidirectional regulation through antibodies and immune complexes, BAFF/APRIL signaling, cytokines, chemokines, and metabolic cues. These interactions are further shaped by tumor cells, stromal components, microorganisms, and other immune populations within the tumor microenvironment. From the perspective of B cell–macrophage state coupling, this review systematically summarizes the biological foundations and reciprocal communication mechanisms underlying their interactions, with particular emphasis on their dynamic remodeling across different disease stages, tertiary lymphoid structures, distinct spatial niches within tumors, and metastatic progression. We further evaluate how established therapies and emerging experimental interventions influence this cellular network. Current evidence suggests that specific B-cell and macrophage states may form distinct functional combinations within either immune-supportive or immunosuppressive ecosystems. However, direct causal evidence remains limited, and the reproducibility of these associations across independent patient cohorts has yet to be firmly established. Future studies should integrate single-cell sequencing, B-cell receptor clonotype tracking, spatial multi-omics, and functional perturbation approaches to move beyond cellular co-occurrence and computationally inferred communication toward direct validation of functional dependencies. Such efforts will also be essential for determining whether composite state–spatial signatures can improve patient stratification, therapeutic response prediction, and treatment decision-making.